121 related articles for article (PubMed ID: 23564770)
1. Secretory phospholipase A2 mediates human esophageal adenocarcinoma cell growth and proliferation via ERK 1/2 pathway.
Sadaria MR; Yu JA; Meng X; Fullerton DA; Reece TB; Weyant MJ
Anticancer Res; 2013 Apr; 33(4):1337-42. PubMed ID: 23564770
[TBL] [Abstract][Full Text] [Related]
2. Group IIa sPLA2 inhibition attenuates NF-κB activity and promotes apoptosis of lung cancer cells.
Yu JA; Kalatardi S; Dohse J; Sadaria MR; Meng X; Fullerton DA; Weyant MJ
Anticancer Res; 2012 Sep; 32(9):3601-7. PubMed ID: 22993297
[TBL] [Abstract][Full Text] [Related]
3. Secretory phospholipase A2 inhibition attenuates intercellular adhesion molecule-1 expression in human esophageal adenocarcinoma cells.
Sadaria MR; Meng X; Fullerton DA; Reece TB; Shah RR; Grover FL; Weyant MJ
Ann Thorac Surg; 2011 May; 91(5):1539-45. PubMed ID: 21396625
[TBL] [Abstract][Full Text] [Related]
4. Modulation of growth in human esophageal adenocarcinoma cells by group IIa secretory phospholipase A(2).
Mauchley D; Meng X; Johnson T; Fullerton DA; Weyant MJ
J Thorac Cardiovasc Surg; 2010 Mar; 139(3):591-9; discussion 599. PubMed ID: 20176206
[TBL] [Abstract][Full Text] [Related]
5. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
[TBL] [Abstract][Full Text] [Related]
6. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
[TBL] [Abstract][Full Text] [Related]
7. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
Rivas MA; Carnevale RP; Proietti CJ; Rosemblit C; Beguelin W; Salatino M; Charreau EH; Frahm I; Sapia S; Brouckaert P; Elizalde PV; Schillaci R
Exp Cell Res; 2008 Feb; 314(3):509-29. PubMed ID: 18061162
[TBL] [Abstract][Full Text] [Related]
8. The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERRγ through AKT and ERK1/2.
Sun Y; Wang C; Yang H; Ma X
Eur J Cancer Prev; 2014 Sep; 23(5):418-24. PubMed ID: 25068805
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of secretory phospholipase A2-induced cytokine production in human lung macrophages by budesonide.
Triggiani M; Granata F; Petraroli A; Loffredo S; Frattini A; Staiano RI; Monaco G; Marone G
Int Arch Allergy Immunol; 2009; 150(2):144-55. PubMed ID: 19439980
[TBL] [Abstract][Full Text] [Related]
10. Secretory Phospholipase A2 IIa Mediates Expression of Growth Factor Receptors in Esophageal Adenocarcinoma.
Halpern AL; Kohtz PD; White AM; Houk AK; Rehring JF; Hanson L; McCarter MD; Joshi M; Meng X; Fullerton DA; Weyant MJ
Dig Dis Sci; 2021 Mar; 66(3):784-795. PubMed ID: 32277371
[TBL] [Abstract][Full Text] [Related]
11. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
12. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways.
Secchiero P; Gonelli A; Carnevale E; Milani D; Pandolfi A; Zella D; Zauli G
Circulation; 2003 May; 107(17):2250-6. PubMed ID: 12668516
[TBL] [Abstract][Full Text] [Related]
13. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
14. Biphasic regulation of extracellular signal-regulated kinases by scalaradial, a secretory phospholipase A(2) inhibitor.
Xie Y; Yu Z; Liu L; Guo Y; Lou L
Cancer Biol Ther; 2006 Aug; 5(8):988-92. PubMed ID: 16760675
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of peripheral benzodiazepine receptor ligand-induced apoptosis and cell cycle arrest of esophageal cancer cells by simultaneous inhibition of MAPK/ERK kinase.
Sutter AP; Maaser K; Gerst B; Krahn A; Zeitz M; Scherübl H
Biochem Pharmacol; 2004 May; 67(9):1701-10. PubMed ID: 15081869
[TBL] [Abstract][Full Text] [Related]
16. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
Mut M; Lule S; Demir O; Kurnaz IA; Vural I
Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
[TBL] [Abstract][Full Text] [Related]
17. NO donor and MEK inhibitor synergistically inhibit proliferation and invasion of cancer cells.
Furuhashi S; Sugita H; Takamori H; Horino K; Nakahara O; Okabe H; Miyake K; Tanaka H; Beppu T; Baba H
Int J Oncol; 2012 Mar; 40(3):807-15. PubMed ID: 22025280
[TBL] [Abstract][Full Text] [Related]
18. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
Kim SH; Song YC; Kim SH; Jo H; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():642-8. PubMed ID: 19723115
[TBL] [Abstract][Full Text] [Related]
19. Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells.
Banudevi S; Senthilkumar K; Sharmila G; Arunkumar R; Vijayababu MR; Arunakaran J
Clin Chim Acta; 2010 Feb; 411(3-4):172-8. PubMed ID: 19913001
[TBL] [Abstract][Full Text] [Related]
20. Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor-mediated PI3K feedback loop activation via ERK1/2 and AKT.
Svejda B; Kidd M; Kazberouk A; Lawrence B; Pfragner R; Modlin IM
Cancer; 2011 Sep; 117(18):4141-54. PubMed ID: 21387274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
